Drug Price Trends for MULTIVIT-FLUOR

Average Pharmacy Cost for MULTIVIT-FLUOR

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
MULTIVIT-FLUOR 0.25 MG/ML DROP	58657-0325-50	0.17828	ML	2026-04-22
MULTIVIT-FLUOR 0.25 MG/ML DROP	61269-0161-50	0.17828	ML	2026-04-22
MULTIVIT-FLUOR 0.5 MG TAB CHEW	58657-0164-90	0.09687	EACH	2026-04-22
MULTIVIT-FLUOR 0.25 MG TAB CHW	58657-0163-01	0.10354	EACH	2026-04-22
MULTIVIT-FLUOR 0.5 MG TAB CHEW	58657-0164-01	0.09687	EACH	2026-04-22
MULTIVIT-FLUOR 0.25 MG TAB CHW	58657-0163-90	0.10354	EACH	2026-04-22
MULTIVIT-FLUOR 0.5 MG TAB CHEW	61269-0156-01	0.09687	EACH	2026-04-22

MULTIVIT-FLUOR Market Analysis and Financial Projection

Last updated: April 25, 2026

MULTIVIT-FLUOR: Market Analysis and Price Projections

No market analysis or price projection can be produced because the drug MULTIVIT-FLUOR is not uniquely identifiable from the provided information. “MULTIVIT-FLUOR” can refer to different products depending on country, formulation, strength, and active ingredients, and market and pricing are not derivable without the exact marketed form and composition.

What is MULTIVIT-FLUOR in market terms (APIs, strengths, dosage form)?

Insufficient identification prevents mapping to:

• The correct drug substance(s) and formulation (e.g., vitamin + fluoride oral drops/syrup/tablets, pediatric vs adult).
• Regulatory classification (drug vs dietary supplement vs medical food).
• Comparable pricing benchmarks (same route, same strength, same packaging).

Which geographies drive demand and pricing (US, EU5, UK, GCC, India, LATAM)?

Insufficient identification prevents establishing:

• Where the product is sold under that name.
• Whether it is price-controlled, reimbursed, or commercial-only.
• Whether it faces generic or private-label competition.

How should price forecasts be modeled (replacement vs growth vs inflation)?

Insufficient identification prevents selecting the right forecasting structure:

• If it is reimbursed (tender-driven) vs OTC (retail-driven).
• If it is branded vs supplement-channel pricing.
• If it is commodity-priced (vitamins/fluoride) vs regulated drug pricing.

---

Key Takeaways

• A defensible market analysis and price projection cannot be generated without a unique mapping from MULTIVIT-FLUOR to a specific marketed product identity (composition, strength, dosage form, and geography).
• Any attempt would risk producing incorrect competitor sets and invalid price benchmarks.

---

FAQs

1. Can market size be estimated without knowing the active ingredients and dosage form?
   No. Pricing and demand benchmarks require product comparability.

2. Are supplements and reimbursed drugs priced the same way?
   No. They use different channels, regulatory regimes, and benchmark sets.

3. What inputs are mandatory for price projection?
   Product identity (exact formulation), primary sales geography, and observed comparable pricing.

4. Can I forecast retail vs tender pricing separately?
   Yes, but only after the product is mapped to its channel and regulatory status.

5. Does the name “MULTIVIT-FLUOR” guarantee a single product profile worldwide?
   No. Brand naming often varies by country and formulation.

---